Novavax Inc (NVAX NASDAQ) stock market data APIs
$6.7986
-0.11(-1.6%)
as of July 3, 2025
Try our APIs with
free plan!
Novavax Inc Financial Data Overview
Price chart is built with
Anychart
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Prev. Close
6.7986
Open
6.6883
High
6.8167
Low
6.7685
52 wk Range
5.01-17.81
Market Cap
1 101 M
P/E Ratio
2.4727
Shares Outstanding
162 M
Revenue
1 255 M
EPS
2.93
Beta
2.771
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Novavax Inc data using free add-ons & libraries
Get Novavax Inc Fundamental Data
Novavax Inc Fundamental data includes:
- Net Revenue: 1 255 M
- EBITDA: 468 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-08
- EPS/Forecast: 0.7085
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Novavax Inc News
New
Leaked memo reportedly shows biotech lobby group’s opposition to RFK Jr.
[HHS Secretary Robert F. Kennedy Jr. Testifies During House Hearing] Kayla Bartkowski/Getty Images News One of the leading lobby groups of the biotech industry, Biotechnology Innovation Organization ...
FDA's Prasad overruled agency scientists in restricting use of COVID shots - report
[Broward Health Hospital Administers First Of Its Moderna Vaccine] Joe Raedle/Getty Images News The leader of the U.S. FDA's division that oversees vaccines, Vinay Prasad, overruled the recommendatio...
COVID shot makers in focus as RFK Jr. revamps vaccine injury compensation program
[Healthcare coronavirus vaccine arrangement] Mirela Gherban Health Secretary Robert F. Kennedy Jr. said that a newly appointed team will look for ways to widen the National Vaccine Injury Compensatio...
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade
Novavax (NVAX) closed at $6.36 in the latest trading session, marking a -2.15% move from the prior day. This move lagged the S&P 500's daily gain of 0.52%. On the other hand, the Dow registered a gain...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
